Yizi He

Changsha, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

PUF, a biflavone monomer, triggers DNA damage through SLC25A15 downregulation and purine metabolic suppression in DLBCL.

PUF, a biflavone monomer, triggers DNA damage through SLC25A15 downregulation and purine metabolic suppression in DLBCL.

Journal: Journal of translational medicine
Published: October 25, 2025

Targeting metabolic reprogramming in multiple myeloma: Molecular mechanisms and potential therapeutic targets.

Targeting metabolic reprogramming in multiple myeloma: Molecular mechanisms and potential therapeutic targets.

Journal: Critical reviews in oncology/hematology
Published: April 23, 2025

Comments on "Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis".

Comments on "Adverse Events Associated With Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis".

Journal: Gastroenterology
Published: March 10, 2025

Can High-Resolution Microendoscopy Be Widely Adopted for Esophageal Cancer Screening in Low-Resource Settings?

Can High-Resolution Microendoscopy Be Widely Adopted for Esophageal Cancer Screening in Low-Resource Settings?

Journal: Gastroenterology
Published: March 08, 2025

Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangitis: Letter to the editor on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial".

Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangitis: Letter to the editor on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial".

Journal: Clinical and molecular hepatology
Published: March 01, 2025

Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma.

Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma.

Journal: Cancer cell international
Published: February 28, 2025

Radiomic features at contrast-enhanced CT predict proliferative hepatocellular carcinoma and its prognosis after transarterial chemoembolization.

Radiomic features at contrast-enhanced CT predict proliferative hepatocellular carcinoma and its prognosis after transarterial chemoembolization.

Journal: Scientific reports
Published: November 25, 2024

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma.

A novel anti-CD47 antibody with therapeutic potential for NK/T-cell lymphoma.

Journal: Human vaccines & immunotherapeutics
Published: September 30, 2024

Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets.

Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets.

Journal: MedComm
Published: September 04, 2024

POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma.

POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma.

Journal: Scientific reports
Published: August 11, 2024

Increased coexpression of PD-L1 and IDO1 is associated with poor overall survival in patients with NK/T-cell lymphoma.

Increased coexpression of PD-L1 and IDO1 is associated with poor overall survival in patients with NK/T-cell lymphoma.

Journal: Leukemia
Published: January 14, 2024

The patients with multiple myeloma were infected with COVID-19 during autologous stem cell transplantation: case report and literature review.

The patients with multiple myeloma were infected with COVID-19 during autologous stem cell transplantation: case report and literature review.

Journal: Infectious agents and cancer
Published: December 27, 2023
Showing 1-12 of 24

Last Updated: 09/26/2026